Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1993-9-30
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0042-9007
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
65
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
73-4
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8362520-Adult,
pubmed-meshheading:8362520-Blood Component Transfusion,
pubmed-meshheading:8362520-Blood Group Incompatibility,
pubmed-meshheading:8362520-Humans,
pubmed-meshheading:8362520-Immunization, Passive,
pubmed-meshheading:8362520-Rh Isoimmunization,
pubmed-meshheading:8362520-Rh-Hr Blood-Group System
|
pubmed:year |
1993
|
pubmed:articleTitle |
Dose of anti-D immunoglobulin for the prevention of RhD immunisation after RhD-incompatible platelet transfusions.
|
pubmed:publicationType |
Letter,
Comment
|